CORY SINDELAR - 08 Feb 2024 Form 4 Insider Report for CALIX, INC (CALX)

Role: Chief Financial Officer
Signature: /s/ Tom Gemetti as Attorney-in-Fact for Cory Sindelar
Issuer symbol: CALX
Transactions as of: 08 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 12 Feb 2024, 18:09:55 UTC
Previous filing: 28 Nov 2023
Next filing: 15 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	(CALX)	Stock Option (right to buy)	Award	$0	+54,500		$0.000000	54,500	08 Feb 2024	Common Stock	54,500	$51.55	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 54,500 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024.

Content

On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 54,500 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024.